DocGo, Inc. (DCGO)
0.2715
-0.01
(-3.72%)
USD |
NASDAQ |
Oct 16, 16:00
0.271
0.00 (0.00%)
After-Hours: 20:00
DocGo Research and Development Expense (Annual) : 13.56M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 13.56M |
| December 31, 2024 | 11.59M |
| December 31, 2023 | 10.86M |
| Date | Value |
|---|---|
| December 31, 2022 | 5.385M |
| December 31, 2021 | 3.320M |
| December 31, 2020 | 1.190M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Dogecoin Cash, Inc. | -- |
| Cryo-Cell International, Inc. | 0.3763M |
| Privia Health Group, Inc. | -- |
| Strata Critical Medical, Inc. | 3.052M |
| Syra Health Corp. | 0.0678M |